| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |